Literature DB >> 1350846

Prevalence of Leishmania infection among AIDS patients.

J Alvar, B Gutiérrez-Solar, R Molina, R López-Velez, A Garcia-Camacho, P Martinez, F Laguna, E Cercenado, A Galmes.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1350846     DOI： 10.1016/0140-6736(92)91255-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model.

Authors:  M Paul; R Durand; H Fessi; D Rivollet; R Houin; A Astier; M Deniau
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Treating HIV/AIDS and leishmaniasis coinfection in Ethiopia.

Authors:  Aranka Anema; Koert Ritmeijer
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

3.  Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.

Authors:  G Angarano; P Maggi; S L Coppola; R L Cavaliere
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

4.  Pyrexia of undetermined origin in advanced HIV disease.

Authors:  C M Tang; C P Conlon; R F Miller
Journal:  Genitourin Med       Date:  1997-08

5.  Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

Authors:  J P Gangneux; A Sulahian; Y J Garin; R Farinotti; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 6.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

7.  Changing epidemiology of visceral leishmaniasis in northeastern Brazil: a 25-year follow-up of an urban outbreak.

Authors:  Ádila L M Lima; Iraci D de Lima; José F V Coutinho; Úrsula P S T de Sousa; Marcos A G Rodrigues; Mary E Wilson; Richard D Pearson; José W Queiroz; Selma M B Jerônimo
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-10-01       Impact factor: 2.184

8.  Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients.

Authors:  C Amela; D López-Gay; J C Alberdi; J Castilla
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

9.  Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

Authors:  J A Pineda; J A Gallardo; J Macías; J Delgado; C Regordán; F Morillas; F Relimpio; J Martín-Sánchez; A Sánchez-Quijano; M Leal; E Lissen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients.

Authors:  R Piarroux; F Gambarelli; H Dumon; M Fontes; S Dunan; C Mary; B Toga; M Quilici
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.